US Stock MarketDetailed Quotes

MRZM Marizyme

Watchlist
  • 0.088430
  • 0.0000000.00%
Close Mar 27 16:00 ET
4.13MMarket Cap-47P/E (TTM)

About Marizyme Company

Marizyme, Inc. is a biotechnology company which engages in the acquisition, development, and commercialization of therapies that minimize mortality and costs in the acute care space. It offers DuraGraft, a one-time intraoperative vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure, and Krillase, a patented protease-based therapeutic. The company was founded on March 20, 2007 and is headquartered in Jupiter, FL.

Company Profile

SymbolMRZM
Company NameMarizyme
Founded2007
CEOMr. David Barthel
MarketPink Market
Employees15
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address555 Heritage Drive,Suite 200
CityJupiter
ProvinceFlorida
CountryUnited States of America
Zip Code33458
Phone1-561-935-9955

Company Executives

  • Name
  • Position
  • Salary
  • David Barthel
  • Chief Executive Officer, Secretary and Director
  • 58.34K
  • George Kovalyov
  • Chief Financial Officer and Treasurer
  • --
  • Dr. Steven Brooks
  • Executive Vice President of Medical and Regulatory Affairs and Chief Medical Officer
  • 316.67K
  • Dr. Catherine Pachuk
  • Chief Scientific Officer and Executive Vice President
  • 298.75K
  • Harrison Ross
  • Vice President of Finance
  • --
  • Vithalbhai D. Dhaduk
  • Chairman of the Board
  • 48.19K
  • Michael R. Stewart
  • Independent Director
  • --
  • William G. Hearl
  • Independent Director
  • 48.19K
  • Julie Kampf
  • Independent Director
  • 48.19K
  • Terry Brostowin, Esq.
  • Independent Director
  • 48.19K
  • Dr. Nilesh Patel
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg